OVERLAND PARK, Kan.--(BUSINESS WIRE)--Vince & Associates Clinical Research today announced that it has been awarded a contract with the Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), to conduct bioequivalence studies of innovator and generic drugs such as anti-epileptic drugs.
